Stationary phase induction in Escherichia coli--new targets for antimicrobial therapy?
Smith
A W
AW
School of Pharmacy and Pharmacology, University of Bath, Claverton Down, UK.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002453:Cell Cycle; D015195:Drug Design; D004926:Escherichia coli / Q000235:genetics / Q000502:physiology*; D015964:Gene Expression Regulation, Bacterial; D012808:Sigma Factor / Q000235:genetics / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012808:Sigma Factor; C069567:sigma factor KatF protein, Bacteria